COMPANY

InterVene

HQ: Redwood City, CA source · intervene-med.com ↗

Keywords: in-stent restenosis Chronic Venous Insufficiency Venous Thrombosis Venous Obstruction Chronic Venous Disease CVI Chronic Venous Insufficiency Thrombosis (Stent Thrombosis) Embolism and Thrombosis Thrombectomy Deep Vein Reflux Recanalization and debulking Recana Thrombectomy Catheter System BlueLeaf System BlueLeaf® Endovenous Valve Formation System ReLeaf

Location: Redwood City, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

7Trials (company is sponsor)

Timeline

2026-08 Trial start —: The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry source ↗
Oct 18, 2025 Trial start Not phased (device or behavioral study): RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK) source ↗
Jul 2, 2025 Trial start Not phased (device or behavioral study): RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL) source ↗
Oct 1, 2022 Trial start Not phased (device or behavioral study): Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-Canada) source ↗
Feb 13, 2020 Trial start Not phased (device or behavioral study): Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-US) source ↗
Nov 2, 2017 Trial start Not phased (device or behavioral study): Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System source ↗
Sep 9, 2015 Trial start Not phased (device or behavioral study): A Feasibility Study of the ReLeaf Catheter System source ↗

Upcoming milestones

Apr 30, 2027 (ESTIMATED) · Not phased · RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL) · NCT07095660
2027-07 (ESTIMATED) · Not phased · RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK) · NCT07219758
2028-12 (ESTIMATED) · · The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry · NCT07529756

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 7

Record	Title	Phase	Status	Start	Primary completion
NCT07529756	The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry	Not listed	Not yet recruiting	2026-08	2028-12 (estimated)
NCT07095660	RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)	Not phased (device or behavioral study)	Recruiting	Jul 2, 2025	Apr 30, 2027 (estimated)
NCT07219758	RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)	Not phased (device or behavioral study)	Recruiting	Oct 18, 2025	2027-07 (estimated)
NCT03216005	Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System	Not phased (device or behavioral study)	Terminated	Nov 2, 2017	Oct 30, 2023 (actual)
NCT04225806	Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-US)	Not phased (device or behavioral study)	Terminated	Feb 13, 2020	Sep 30, 2023 (actual)
NCT05047302	Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-Canada)	Not phased (device or behavioral study)	Withdrawn	Oct 1, 2022	Nov 1, 2025 (estimated)
NCT02462096	A Feasibility Study of the ReLeaf Catheter System	Not phased (device or behavioral study)	Terminated	Sep 9, 2015	Oct 8, 2016 (actual)